Biotech
Caladrius Biosciences and Cend Therapeutics Announce Poster Presentation at the 2022 American Society of Clinical Oncology Annual Meeting
Poster Presentation to highlight ongoing clinical study of CEND-1 with FOLFIRINOX-based therapies in pancreatic, colorectal and appendiceal cancers BASKING RIDGE, N.J. and SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) more...
Biotech
Achieve Life Sciences Announces Participation at LD Micro Invitational Conference
SEATTLE and VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine more...
Biotech
ENOB News: Johnson Fistel, Globally-Recognized Law Firm, Encourages Shareholders to Submit Their Losses Due to Co-Founder’s Conspiracy of Murder for Hire
SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP ( www.JohnsonFistel.com ) is investigating whether Enochian Biosciences, Inc. (“Enochian” or the “Company”) (NASDAQ: ENOB), any of its executive officers, more...
Biotech
Affimed to Present at the 2022 Jefferies Healthcare Conference
HEIDELBERG, Germany, May 26, 2022 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that its more...
Biotech
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates PSB, GTYH, CLBS, FSI
NEW YORK, NY / ACCESSWIRE / May 25, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary more...
Biotech
Enochian BioSciences Board Learns of Arrest of Co-Founder and Inventor and Expresses Strong Confidence in the Promising Future of the Company
The Board learned of the arrest of Dr. Serhat Gumrukçu after the Press Release by the Department of Justice on May 25, 2022; The Board has verified that the incident leading to the arrest occurred more...
Biotech
Affimed N.V. (AFMD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
The market expects Affimed N.V. (AFMD) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2022. This widely-known consensus outlook is important in assessing the more...
Biotech
Aerie (AERI) Starts Late-Stage Study to Treat Dry Eye Disease
Aerie Pharmaceuticals AERI announced that it has started dosing patients in the phase III COMET-2 study with AR-15512, its investigational ophthalmic solution, for the treatment of signs and symptoms of dry eye disease (DED). While more...
Biotech
INmune Bio (INMB) Down on Clinical Hold for Alzheimer’s Study
Shares of INmune Bio, Inc. INMB were down 24.6% on Tuesday after the company reported that it has received an email from the FDA on May 20, stating that the regulatory body has placed a more...
Biotech
Celyad SA (CYAD) Upgraded to Buy: Here’s What You Should Know
Celyad SA (CYAD) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates — one of the most more...